Hims & Hers (NYSE: HIMS) has put investors on a roller coaster ride in 2025. *Stock prices used were the afternoon prices of ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications ...

Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.

When investors choose to risk their capital in an individual company, they must be aware that the stock market isn’t the ...

Yahoo Finance host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute, including Snowflake (SNOW) shares seeing continued gains after posting its first-ever ...

Investing.com -- Analysts at Citi and Bank of America are maintaining a cautious stance on Hims & Hers Health as competition in the GLP-1 space intensifies and growth begins to moderate.

Hims & Hers stock took a nosedive after Cigna’s Evernorth division announced a $200 monthly cap on popular weight-loss drugs ...

Short sellers have faced staggering losses exceeding $250 billion in the latest market rally, with Nvidia (NVDA) and Tesla ...

Investors usually focus on stocks that already have stellar dividend yields, but your portfolio could also benefit from ...

Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...

Marqeta is winning migration deals, which leads to immediate volume transfer. Click here to read an analysis of MQ stock now.

Shares of Apple Inc (NASDAQ:AAPL) continued to dip Thursday following OpenAI’s $6.5 billion acquisition of io Products, a design startup led by former Apple designer Jony Ive. The move, seen by many ...